U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07316231) titled 'Evaluating the Accuracy and Practical Utility of AI-Enhanced 12-Lead ECG' on Dec. 20, 2025.
Brief Summary: Atrial fibrillation (AF) is a major cause of heart failure and ischemic stroke, making early detection and intervention critically important. However, timely ECG recording during paroxysmal episodes is often difficult, leading to delayed diagnosis. Recently, an AI-enhanced 12-lead ECG equipped with a "hidden AF risk estimation" function has been introduced. This technology analyzes sinus rhythm ECGs and stratifies the likelihood of prior AF into four risk categories. Although this novel approach may facilitate earlier AF detecti...